BUBR1 (BUB1B) Antibody (N-term) Blocking peptide

Artikelnummer: ABT-BP8059A
Artikelname: BUBR1 (BUB1B) Antibody (N-term) Blocking peptide
Artikelnummer: ABT-BP8059A
Hersteller Artikelnummer: BP8059a
Alternativnummer: ABT-BP8059A-500UG
Hersteller: Abcepta
Kategorie: Proteine/Peptide
Alternative Synonym: Mitotic checkpoint serine/threonine-protein kinase BUB1 beta, MAD3/BUB1-related protein kinase, hBUBR1, Mitotic checkpoint kinase MAD3L, Protein SSK1, BUB1B, BUBR1, MAD3L, SSK1
BUB1B, a member of the Ser/Thr protein kinase family, is a probable component of the mitotic checkpoint that delays anaphase until all chromosomes are properly attached to the mitotic spindle. It can interact with BUB3, CENP-F, CENP-E and mitosin, and can be localized to nuclear kinetochores. This protein is highly expressed in thymus and spleen. The CD1 domain directs kinetochore localization and binding to BUB3. The protein possesses a cyclin destruction box sequence, which targets protein for rapid degradation by ubiquitin-dependent proteolysis during the transition from mitosis to interphase. Defects in BUB1B are associated with tumor formation.
NCBI: 701
UniProt: O60566
Formulierung: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
Target-Kategorie: The synthetic peptide sequence used to generate the antibody AP8059a was selected from the N-term region of human BUB1B . A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.